Vincent Arnold

Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial

Jesús S. Mora, Angela Genge, Adriano Chiò et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2019 · 222 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial

Beatriz Grinsztejn, Nathalie De Castro, Vincent Arnold et al. · The Lancet Infectious Diseases · 2014 · 98 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Summary of the Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and Adults

Laurence L. Greenhill, S R Pliszka, Mina K. Dulcan et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2001 · 88 citations · Full text

Pharmacy, Pediatrics, Pharmacotherapy +14

S100A9 protein is a novel ligand for the CD85j receptor and its interaction is implicated in the control of HIV-1 replication by NK cells

Vincent Arnold, Jean-Saville Cummings, Uriel Y. Moreno‐Nieves et al. · Retrovirology · 2013 · 51 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

The CD85j+ NK Cell Subset Potently Controls HIV-1 Replication in Autologous Dendritic Cells

Daniel Scott‐Algara, Vincent Arnold, Céline Didier et al. · PLoS ONE · 2008 · 40 citations · Full text

Life Sciences, Immunology, Infectious Diseases +11